%0 Journal Article
%T 胃食管反流病的药物及内镜治疗的现状
The Current Status of Pharmacological and Endoscopic Treatments for Gastroesophageal Reflux Disease
%A 袁希惠
%A 任金凤
%A 杨正英
%A 杨敏媛
%A 刘天宇
%J Advances in Clinical Medicine
%P 2468-2476
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.153883
%X 胃食管反流病(Gastroesophageal Reflux Disease, GERD)是一种常见的消化系统疾病,其治疗包括药物和内镜治疗。质子泵抑制剂(Proton Pump Inhibitors, PPIs)仍是主要药物,钾–氢泵抑制剂(Potassium-Competitive Acid Blockers, P-CABs)等新型药物逐步应用。内镜治疗技术不断发展,为药物难治性GERD提供了新选择。本文综述GERD的药物及内镜治疗的现状,分析其疗效、局限性,并展望未来发展方向,以期为临床治疗提供参考。
Gastroesophageal Reflux Disease (GERD) is a common digestive disorder, with treatment strategies including pharmacological and endoscopic therapies. Proton Pump Inhibitors (PPIs) are still the main drugs, while novel agents such as Potassium-Competitive Acid Blockers (P-CABs) are increasingly utilized. Advances in endoscopic techniques offer new therapeutic options for drug-refractory GERD. This review summarizes the current status of pharmacological and endoscopic treatments for GERD, discusses their efficacy and limitations, and explores future perspectives to provide a reference for clinical treatment.
%K 胃食管反流病,
%K 药物治疗,
%K 内镜治疗,
%K 综述
Gastroesophageal Reflux Disease
%K Pharmacological Treatment
%K Endoscopic Treatment
%K Review
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=110270